Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
IOVA Iovance Biotherapeutics
- 3.900
- +0.170+4.56%
Close Mar 11 16:00 ET
- 3.919
- +0.019+0.49%
Post 19:47 ET
1.28BMarket Cap-3.05P/E (TTM)
3.970High3.710Low8.03MVolume3.745Open3.730Pre Close31.08MTurnover3.19%Turnover RatioLossP/E (Static)327.88MShares15.90052wk High1.80P/B982.28MFloat Cap3.58052wk Low--Dividend TTM251.87MShs Float165.000Historical High--Div YieldTTM6.97%Amplitude1.000Historical Low3.870Avg Price1Lot Size
Iovance Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.44%-352.98M | 12.71%-73.3M | 29.86%-58.97M | -4.77%-98.43M | -22.51%-122.28M | -23.59%-361.82M | -8.11%-83.97M | -32.10%-84.08M | -21.02%-93.95M | -35.25%-99.82M |
| Net income from continuing operations | 16.18%-372.18M | 32.50%-78.56M | 26.56%-83.54M | 8.85%-97.1M | -5.22%-112.98M | -12.16%-444.04M | -10.50%-116.38M | -14.20%-113.76M | -7.23%-106.53M | -17.21%-107.37M |
| Operating gains losses | -8,304.29%-5.74M | -5,149.06%-5.56M | -126.05%-93K | --10K | ---96K | --70K | ---106K | --357K | ---- | ---- |
| Depreciation and amortization | 31.63%43.61M | 20.31%11.69M | 12.89%11.15M | 38.55%10.86M | 73.90%9.91M | 56.74%33.13M | 70.21%9.71M | 89.83%9.88M | 49.41%7.84M | 14.44%5.7M |
| Deferred tax | 18.71%-2.83M | 188.63%1.56M | -22.37%-1.52M | -205.66%-1.46M | ---1.41M | ---3.48M | ---1.76M | ---1.24M | ---477K | --0 |
| Change In working capital | -1,779.40%-122.56M | -419.47%-37.98M | -326.10%-13.32M | -237.50%-38.71M | -153.71%-32.55M | -125.48%-6.52M | 295.87%11.89M | -45.73%5.89M | -77.66%-11.47M | -24.64%-12.83M |
| -Change in receivables | -46,335.57%-69.19M | -9,008.72%-13.57M | -73,324.24%-24.16M | -94,960.61%-31.37M | ---83K | ---149K | ---149K | --33K | ---33K | --0 |
| -Change in inventory | -294.51%-39.92M | -1,357.20%-13.45M | -3,171.47%-10.87M | 7.23%-8.86M | ---6.74M | ---10.12M | ---923K | --354K | ---9.55M | --0 |
| -Change in prepaid assets | 79.00%-2.11M | -3.30%-5.32M | -214.92%-2.47M | 92.55%-211K | 239.16%5.89M | -372.39%-10.06M | -280.89%-5.15M | 192.92%2.15M | -368.88%-2.83M | -13.89%-4.23M |
| -Change in payables and accrued expense | -97.00%737K | -109.54%-1.99M | 340.18%27.14M | 21.44%4.42M | -378.19%-28.83M | 1,984.92%24.6M | 744.95%20.83M | -55.02%6.17M | 147.11%3.64M | 17.05%-6.03M |
| -Change in other current liabilities | -11.86%-12.07M | -34.23%-3.65M | -4.69%-2.95M | 0.11%-2.69M | -8.56%-2.79M | -455.82%-10.79M | -17.85%-2.72M | -424.81%-2.81M | -1,369.81%-2.69M | -472.32%-2.57M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.44%-352.98M | 12.71%-73.3M | 29.86%-58.97M | -4.77%-98.43M | -22.51%-122.28M | -23.59%-361.82M | -8.11%-83.97M | -32.10%-84.08M | -21.02%-93.95M | -35.25%-99.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 37.90%-96.41M | 132.50%23.68M | 38.24%-48.8M | 125.65%40.22M | -172.69%-111.51M | -160.53%-155.24M | -15,901.52%-72.85M | -207.19%-79.01M | -263.72%-156.78M | 77.30%153.4M |
| Net PPE purchase and sale | 50.34%-11.07M | -18.11%-4.17M | 36.04%-2.29M | 95.36%-442K | 26.36%-4.17M | -9.13%-22.29M | -16.78%-3.53M | -157.89%-3.58M | -108.04%-9.52M | 50.49%-5.66M |
| Net business purchase and sale | 75.28%-52.57M | --0 | --0 | --0 | ---52.57M | ---212.63M | --253K | ---3.38M | ---209.51M | --0 |
| Net investment purchase and sale | -141.13%-32.77M | 140.03%27.85M | 35.45%-46.51M | -34.68%40.66M | -134.43%-54.76M | -71.22%79.68M | -2,097.39%-69.57M | -195.95%-72.06M | -37.96%62.25M | 62.38%159.06M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 37.90%-96.41M | 132.50%23.68M | 38.24%-48.8M | 125.65%40.22M | -172.69%-111.51M | -160.53%-155.24M | -15,901.52%-72.85M | -207.19%-79.01M | -263.72%-156.78M | 77.30%153.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -15.62%390.66M | 140.02%2.31M | -79.31%41.95M | 14,809.76%152.83M | -25.02%193.58M | 143.47%462.96M | -99.50%962K | 90,033.33%202.8M | 149.59%1.03M | 18,119.62%258.17M |
| Net common stock issuance | -14.24%397.3M | --0 | -76.61%47.52M | --151.87M | -23.91%197.91M | 144.47%463.28M | -100.00%1K | --203.18M | --0 | --260.1M |
| Proceeds from stock option exercised by employees | 151.44%6.22M | 178.03%3.19M | --713K | 47.21%1.95M | --364K | -24.99%2.47M | 6.90%1.15M | --0 | 127.84%1.33M | --0 |
| Net other financing activities | -360.04%-12.86M | -373.12%-880K | -1,556.20%-6.28M | -232.23%-1M | -143.70%-4.7M | -5.51%-2.8M | ---186K | ---379K | ---301K | ---1.93M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -15.62%390.66M | 140.02%2.31M | -79.31%41.95M | 14,809.76%152.83M | -25.02%193.58M | 143.47%462.96M | -99.50%962K | 90,033.33%202.8M | 149.59%1.03M | 18,119.62%258.17M |
| Net cash flow | ||||||||||
| Beginning cash position | -23.87%181.32M | -48.96%170.54M | -20.69%235.11M | -74.43%140.62M | -23.87%181.32M | 182.47%238.16M | 167.76%334.15M | 158.89%296.44M | 458.61%549.91M | 182.47%238.16M |
| Current changes in cash | -8.54%-58.72M | 69.64%-47.31M | -265.78%-65.82M | 137.89%94.62M | -112.90%-40.21M | -135.17%-54.1M | -237.48%-155.85M | 285.80%39.7M | -1,654.74%-249.71M | 2,106.16%311.75M |
| Effect of exchange rate changes | 80.26%-541K | -138.99%-1.18M | 162.87%1.25M | 96.68%-125K | ---491K | ---2.74M | --3.02M | ---1.99M | ---3.77M | --0 |
| End cash Position | -32.69%122.05M | -32.69%122.05M | -48.96%170.54M | -20.69%235.11M | -74.43%140.62M | -23.87%181.32M | -23.87%181.32M | 167.76%334.15M | 158.89%296.44M | 458.61%549.91M |
| Free cash flow | 5.22%-364.05M | 11.47%-77.46M | 30.12%-61.26M | 4.45%-98.87M | -19.88%-126.45M | -22.65%-384.11M | -8.43%-87.5M | -34.79%-87.66M | -25.86%-103.47M | -23.74%-105.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |